Pembrolizumab Plus Lenvatinib in Unresectable Cutaneous Angiosarcoma Patients

Clinical trial NCT06673628 · RECRUITING

Trial details

NCT number: NCT06673628
Sponsor: National Cancer Center, Japan
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Angiosarcoma of Skin Angiosarcoma Metastatic

Start date: 2024-12-01
Primary completion: 2028-11-30
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.